DALLAS, Sept. 20, 2019 /PRNewswire/ -- Eclipse, a leading manufacturer of regenerative medicine devices, has upgraded its popular eVive™ pulse wave therapy system to exceed expectations in high volume practices.

BOSTON, Sept. 20, 2019 /PRNewswire/ -- Today, 3,000 Blue Cross Blue Shield of Massachusetts associates are volunteering at s

VANCOUVER, British Columbia, Sept. 20, 2019 /PRNewswire/ -- Natreve, the world's first certified plastic-neutral wellness and supplement company, is proud to announce its new partnership

PERTH, Australia and BILLERICA, Mass., Sept. 20, 2019 /PRNewswire/ -- Murdoch University and Bruker (Nasdaq: BRKR) today announced a strategic collaboration that will help transform the prevention and diagnosis of disease and personalised health around the world. The Murdoch-Bruker collaboration wi

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2019 annual general meeting of sharehol

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., Sept. 20, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that The Lancet has

INDIANAPOLIS, Sept. 20, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending an update to the Trulicity® (dulaglutide) label and indication statement. The committee agreed the label should include results from the REWIND

STAINES-UPON-THAMES, United Kingdom, Sept. 20, 2019 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a global biopharmaceutical company, will present at the Can

TARRYTOWN, N.Y. and PARIS, Sept. 20, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Dupixent® (dupilumab) in a third indicatio

CHICAGO, Sept. 20, 2019 /PRNewswire/ -- Rush University Medical Center provides the highest quality care of 93 major academic medical centers ranked in the 2019 Quality and Accountability Study by Vizient, Inc., the health care performance improvement organization announced September 19 at its annual conference.